{"id":"W2981369898","doi":"10.1111/apt.15563","title":"<i>HLADQA1*05</i> genotype predicts anti‐drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Academic Medical Organization of Southwestern Ontario; Lawson Health Research Institute","keywords":"Infliximab; Medicine; Discontinuation; Internal medicine; Adverse effect; Inflammatory bowel disease; Gastroenterology; Relative risk; Crohn's disease; Immunology; Confidence interval; Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003724561,0.0002976622,0.0002119716,0.0001016693,0.0001360925,0.00001580833,0.0002545932,0.0001314616,0.00004796057],"category_scores_gemma":[0.000001131237,0.000302892,0.0001311683,0.00005519771,0.0002095494,0.00004451626,0.0001380981,0.0001135103,0.00000902589],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003625133,"about_ca_system_score_gemma":0.0001626313,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002195103,"about_ca_topic_score_gemma":0.000002178517,"domain_scores_codex":[0.9983259,0.00028539,0.0004183269,0.0004058877,0.0001727815,0.0003917524],"domain_scores_gemma":[0.9990417,0.00006097839,0.0002433751,0.0003705057,0.0001161548,0.000167238],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01610927,0.0001924865,0.1561437,0.0001872874,0.001246334,0.00002066665,0.0002559861,0.0002293177,0.8253843,0.000009097755,0.0001318195,0.000089692],"study_design_scores_gemma":[0.008138368,0.0003821662,0.4902677,0.00002317295,0.0008133524,0.00001230806,0.00007679803,0.0005510635,0.4928242,0.00005166001,0.006485543,0.0003737079],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949512,0.002233783,0.00004016118,0.0004435981,0.0005225975,0.001536722,0.0002232829,0.00003274042,0.00001589635],"genre_scores_gemma":[0.9929951,0.00252642,0.0001002523,0.003582543,0.0001796628,0.00009491709,0.0003365046,0.00005903076,0.0001255654],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3341239,"threshold_uncertainty_score":0.9999423,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007811605568876999,"score_gpt":0.2745191577501854,"score_spread":0.2667075521813084,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}